Skip to content

SPTX - Seaport Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Seaport Therapeutics, Inc. Common Stock

SPTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SPTXSeaport Therapeutics, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $26.32
52-wk low: $0.01
Prev close: $13.31
Mkt cap: $1.31B
P/B: 3.0x
Profit margin: +0.0%

Smart money

6 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

6 holders

Combined position$77.3M

CI
Citadel
Ken Griffin · Q2 2026 13F
$4.2M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.3B

Valuation

P/B3.04

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SPTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.31B

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Op margin

+0.0%

ROE

-28.1%

$985K

position

SQ

Squarepoint

Q2 2026 13F

$538K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for SPTX

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Sep 14, 2026, in 24 days

EPS expected

-$0.56

-$0.63 to -$0.51

Revenue expected

$0.00

4 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

+0.02

Change in 30 days

-28.1%

ROA-18.9%

Growth